Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy

NCT01448889 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

180

Enrollment

OTHER_GOV

Sponsor class

Conditions

Nephropathy

Interventions

DRUG: 100% oxigen
DRUG: placebo

Sponsor

Assaf-Harofeh Medical Center